CURRICULUM VITAE
Janet Retseck MD
Janet Retseck MD
Assistant Professor
Department of Medicine
Division of Hematology and Oncology - Medicine
Department of Medicine
Division of Hematology and Oncology - Medicine
OFFICE ADDRESS: |
Froedtert Hospital |
9200 W Wisconsin Ave |
Milwaukee, WI 53226 |
EDUCATION: |
1983 - 1987 B.A., English, cum laude, University of Dallas, Irving, TX |
1987 - 1989 M.A., English, Indiana University, Bloomington, IN |
1990 - 2000 Ph.D., English, Claremont Graduate University, Claremont, CA |
2004 - 2006 Post-Baccalaureate Pre-Medical Program, Scripps College, Claremont, CA |
2006 - 2010 MD, Ohio State University College of Medicine, Columbus, OH |
POSTGRADUATE TRAINING AND FELLOWSHIP APPOINTMENTS: |
2010 - 2013 Residency, Internal Medicine, University of Wisconsin Hospital and Clinics, Madison, WI |
2014 - 2017 Fellowship, Hematology-Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA |
FACULTY APPOINTMENTS: |
2017 - 2020 Physician, Porter Physician Group, Hematology and Oncology, Porter Regional Hospital, Community Health Systems, Valparaiso, IN |
2020 - Present Assistant Professor, VA Medical Center, Milwaukee, WI |
2020 - Present Assistant Professor, Medicine, Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI |
EDUCATIONAL ADMINISTRATIVE APPOINTMENTS: |
2013 - 2014 VA Primary Care Chief, William S. Middleton Veterans Hospital, Madison, WI |
2013 - 2014 Medical Senior Officer of the Day (Fee Basis), William S. Middleton Veterans Hospital, Madison, WI |
SPECIALTY BOARDS AND CERTIFICATION: |
Certificates | Issued By | Issue Date | Expiration |
Internal Medicine | ABIM | 2013 | 2033 |
Hematology | ABIM | 2017 | 2027 |
Oncology | ABIM | 2017 | 2027 |
DEA | 2026 | ||
Licensure | Number | Issue Date | Expiration |
Wisconsin Medical License | 2025 | ||
AWARDS AND HONORS: |
2023 2023 Outstanding Faculty Service Award |
LOCAL/REGIONAL APPOINTED LEADERSHIP AND COMMITTEE POSITIONS: |
2022 - Present MCW Faculty Library Committee |
2022 - Present Tasked with reviewing screening for Veterans with previous malignancies, Lung Cancer Screening Committee, Milwaukee VA |
RESEARCH GRANTS/AWARDS/CONTRACTS/PROJECTS: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
INVITED LECTURES/WORKSHOPS/PRESENTATIONS: |
National |
Retseck J., Sexing Miss Wade, Dickens Symposium, Louisville, KY, 09/1997 |
Retseck J., Reading Baseball/Consuming Baseball, Diamonds in the Desert International Baseball Conference, Tempe, AZ, 03/1998 |
Retseck J., Trollope's Barchester Towers and the Art of Sexuality, Victorian Interdisciplinary Studies Association of the Western United States Annual Conference, Vancouver, WA, 10/1998 |
Retseck J, Department of Medicine Research Day, University of Pittsburgh, Pittsburgh, PA, 05/05/2015 |
Challenges in Cancer Care for Sexual & Gender Minorities, 3rd Annual Cancer Disparities Virtual Symposium, 2021 |
Regional |
Retseck J, Advances in early palliative care, University of Wisconsin Internal Medicine Residency Program, Madison, WI, 11/2011 |
Retseck J, Cook R, DRESS in a patient undergoing treatment for prostate cancer, ACP Wisconsin Chapter Meeting, Wisconsin Dells, WI, 09/2012 |
Retseck J., The Evidence and the Experience: BRCA 1/2 in the Family, University of Wisconsin Internal Medicine Residency Program, Madison, WI, 10/2012 |
Local |
Fellows Breast Conference: 1-2 one-hour lectures a year, 2020 - Present |
Art of Medicine: The Untimely Death of Jane Austen, 2021 |
Retseck J, Puckett L, Lung Cancer Awareness, Tomah VA Grand Rounds, 11/28/2022 |
Art of Medicine: The Untimely Death of Jane Austen, 2022 |
EXTRAMURAL TEACHING: |
Medical Student Education |
2020 - Present Preceptor, M4 Ambulatory Internal Medicine, as needed |
2020 - Present Fellow VA Continuity Clinic, Preceptor, Supervise Hematology-Oncology Fellows in weekly clinic |
2020 - Present Attending, VA Hematology Wards, M3, two interns, resident, fellow |
2021 - 2022 Preceptor, M2 Foundational Capstone |
2021 - 2023 Preceptor, Bench-to-Bedside |
2021 - Present Preceptor, M1-2 Clinical Apprenticeship |
2021 Co-taught M4 Narrative Medicine elective with Bruce Campbell |
2021 - Present Preceptor, PGY-1 Ambulatory Immersion, as needed |
2022 Small Group Facilitator, Foundations of Clinical Medicine |
2022 Facilitator, Patient-Based Discussion, M2 Atherosclerosis Hypercholesterolemia and Leukemia Pilots |
2022 - Present Facilitator, Healer's Art |
04/2024 Course Director, Reading, Writing, Practicing: An Introduction to Narrative Medicine |
BIBLIOGRAPHY |
Books, Chapters, and Reviews |
1. Retseck J. Sexing Miss Wade. Dickens Quarterly. 1998: Dec; 15(4): 217-25. |
Abstracts |
1. Retseck J; A Gillespie-Twardy; A Nasr; HM Lin; Y Lin; J Kirkwood; L Butterfield; H Zahoor; C Sander; AA Tarhini. Long term monitoring of circulating regulatory T cells (Treg), myeloid derived suppressor cells (MDSC) and type I effector T cells in melanoma patients treated with neoadjuvant ipilimumab. In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA): AACR; 2015. Abstract nr 4302. |
2. Campbell TC; AJ Nimunkar; J Retseck; JC Eickhoff; M Backonja; JF Cleary; KL Kwekkeboom; TY Yen. A randomized, double-blind study of “Scrambler” therapy versus sham for painful chemotherapy-induced peripheral neuropathy (CIPN). ASCO, Chicago, IL. May-June 2013. Abstract #115259 |
3. King JD; J Retseck; JC Eickoff; T Hoang; AM Traynor; TC Campbell. Integrated oncopalliative care versus standard care for patients with metastatic lung cancer: A single institution retrospective review. ASCO, Chicago, IL. May-June 2013. Abstract # 116034 |
Peer Reviewed Educational Products |
1. Retseck J. When the Future Is Not Now. J Clin Oncol. 2023 Oct 01;41(28):4592-4594. |
2. Kamaraju T, Atkinson D, Wright T, Charlosn J, Wetzel T, Campbell G, Cadman J, Williams J, Egede L, Retseck J, Banerjee A, Ehrlich V, Stolley M, Power S. Leveraging Social Determinants of Health to Reduce Hospital Length of Stay: A Pilot QI Project for Solid Tumor Oncology Patients During the COVID-19 Pandemic. WMJ. 2022 Oct;121(3):205-211. |
3. Retseck J, Nasr A, Lin Y, Lin H, Mendiratta P, Butterfield LH, Tarhini AA. Long term impact of CTLA4 blockade immunotherapy on regulatory and effector immune responses in patients with melanoma. J Transl Med. 2018 Jul 04;16(1):184. PMCID: PMC6033230 |
4. Retseck J, VanderWeele R, Lin HM, Lin Y, Butterfield LH, Tarhini AA. Phenotypic and functional testing of circulating regulatory T cells in advanced melanoma patients treated with neoadjuvant ipilimumab. J Immunother Cancer. 2016;4:38. PMCID: PMC4915044 |
5. Artinyan A, Nelson R, Soriano P, Chung V, Retseck J, Reynolds J, Marx H, Kim J, Wagman L. Treatment response to transcatheter arterial embolization and chemoembolization in primary and metastatic tumors of the liver. HPB (Oxford). 2008;10(6):396-404. PMCID: PMC2597318 |
6. Pierro M, Zurko J, Szabo A, Cheng YC, Kamaraju S, Burfeind J, Retseck J, Chitambar CR, Chaudhary LN. Matched Case Control Analysis of Breast Cancer- Specific Factors Affecting Risk of Developing SARS-CoV-2 Infection. WMJ. 2023 Dec;122(5):418-421. |